电子健康记录计费代码估算皮肤癌数量的有效性
CPT代码与病理记录强相关(r=0.87),可解释超过75%变异(R2=0.76);ICD代码相关性差(r=0.22)。
要点
- CPT代码与病理证实的皮肤癌数量强相关(r=0.87),可较好代理皮肤癌总数。
- ICD代码与病理记录相关性差(r=0.22),不宜作为皮肤癌数量的代理指标。
- CPT代码可解释皮肤癌数量变异的76%(R2=0.76),优于ICD代码。
核心结论
- ICD代码是每患者皮肤癌数量的差代理指标,而CPT代码是更好的代理指标。
研究设计与样本
- 单中心三级医院(Vanderbilt大学医学中心)2008年7月1日至2018年6月30日的回顾性队列研究。
主要发现
- 6307例患者有至少1个皮肤癌ICD或CPT代码或病理报告,其中5688例同时有皮肤恶性肿瘤相关CPT代码和病理证实的皮肤癌。
- CPT代码数量与病理记录数量呈强线性相关(r=0.87),ICD代码数量与病理记录相关性差(r=0.22)。
- CPT代码可解释皮肤癌数量变异的76%(R2=0.76)。
临床怎么用
- 在缺乏皮肤癌登记系统时,可利用CPT代码估算每患者皮肤癌总数,但不应依赖ICD代码。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Patients can develop multiple skin cancers, and their medical data can be spread over multiple health care systems. This fragmented care, combined with the lack of skin cancer registries, has limited our ability both to provide accurate estimates of incidence and to study the pathogenesis of multiple skin cancers. OBJECTIVE: To assess whether standard diagnostic and procedural codes present in the electronic health records at a single health care system are a valid proxy for estimating the number of overall skin cancers. DESIGN, SETTING, AND PARTICIPANTS: Retrospective cohort study of patients seen at a single-center tertiary care hospital (ie, Vanderbilt University Medical Center) between July 1, 2008, and June 30, 2018. All patients with at least 1 electronic health record-based diagnostic or procedural code for any skin cancer and at least 1 pathology report of a skin cancer. EXPOSURE: The number of International Classification of Disease (ICD) or Current Procedural Terminology (CPT) codes relating to skin cancer. MAIN OUTCOMES AND MEASURES: Pearson correlation coefficient and R2 were calculated for the total number of ICD or CPT codes for skin cancer and histologically verified skin cancers. RESULTS: In this cohort study of 35 901 patients, the mean (SD) age was 70.4 (14.4) years, 20 404 (56.8%) were men, and 31 623 (88.1%) were White individuals. Of these patients, 6307 had at least 1 ICD or CPT code or pathology report for a skin cancer, of whom 5688 patients had both a CPT code related to skin malignancy and a histologically verified skin cancer. There was a strong linear correlation between the number of CPT codes and pathology records (r = 0.87). There was a poor correlation between the number of ICD codes and pathology records (r = 0.22). CONCLUSIONS AND RELEVANCE: This cohort study found that the use of ICD codes was a poor proxy measure for the number of skin cancers per patient. In contrast, CPT codes accounted for more than 75% of the variability in the number of skin cancers (R2 = 0.76) and were a better proxy measure for the total number of skin cancers per patient.
引用
- Anand N, Edwards L, Baker LX, et al. Validity of Using Billing Codes From Electronic Health Records to Estimate Skin Cancer Counts. JAMA Dermatol. 2021. PMID: 34379079. doi:10.1001/jamadermatol.2021.2856
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。